GLOMERULONEPHRITIS-ANTI GBM GN

From NeuroRehab.wiki

Revision as of 20:03, 13 March 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY

1. Characterised by linear deposits of Ig, often IgG & C3 along the glomerular basement membrane on immunofluorescence. Light microscopy: severe necrotizing and crescentic pattern.

2. Dx: confirmed by detection of circulating anti-GBM antibodies.

3. Caused by small vessel vasculitis affecting the capillary beds of the kidneys and lungs.

4. Directly pathogenic autoantibodies: non-collagenous domain of the a3 chain of type IV collagen (Goodpasture’s auto-antigen).

5. Associations: smoking, hydrocarbons, alemtuzumab, genetic (HLA DR2).

6. Presentation: rapidly progressive GN, alveolar haemorrhage (40-60%).

7. Tx: rapidly remove the pathogenic auto-antibody via plasma exchange, steroids, cytotoxic therapy.


Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].